Skip to content

Comparison of ACB With ACB and BiFeS Combination in Knee Arthroplasty Surgeries

Comparison of the Postoperative Analgesic Efficacy of the Combination of Adductor Canal Block and Biceps Femoris Short Head Block Versus Adductor Canal Block Alone in Patients Undergoing Total Knee Arthroplasty

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07233785
Enrollment
60
Registered
2025-11-18
Start date
2025-11-20
Completion date
2026-11-25
Last updated
2025-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain Management, Knee Surgery, Knee Arthroplasty, Total

Keywords

postoperative pain, knee arthroplasty, biceps femoris short head, bifes, adductor canal blok, regional anesthesia

Brief summary

The aim is to compare the postoperative analgesic effects of Adductor Canal and Biceps Femoris Short Head Blocks with Adductor Canal Block in patients undergoing Knee Arthroplasty surgery

Detailed description

Patients were divided into two randomized groups: Group 1 (ACB group, n=30) and Group 2 (ACB+BiFeS group, n=30). All patients will receive the same standard spinal anesthesia per hospital protocol. All blocks will be applied with the same ultrasonography and block equipment, and by the same physician. After the surgery, patients in Group 1 will receive Adductor Canal Block (ACB) with 20 mL of 0.25% bupivacaine. Patients in Group 2 will receive Adductor Canal Block with 20 mL of 0.25% bupivacaine and Biceps Femoris Short Head (BiFeS) with 20 mL of 0.25% bupivacaine. Routine analgesic procedure consisting of 3x400mg Ibuprofen will be followed postoperatively for 24 hours. Numeric Rating Scale (NRS) will be used to assess postoperative pain on 1st, 6th, 12th, 18th and 24th hours after the surgery. Tramadol 1mg/kg IV will be administered as a rescue analgesic for all patients if NRS score is higher than 4. Total Tramadol consumption will be calculated.

Interventions

20 mL of 0.25% bupivacaine

PROCEDUREAdductor Canal Block (ACB) + Biceps Femoris Short Head Block (BiFeS)

20 mL of 0.25% bupivacaine

Sponsors

Cumhuriyet University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients over 18 years of age who underwent percutaneous nephrolithotomy under general anesthesia and were I-II-III according to the American Society of Anesthesiologists (ASA) risk classification were included in the study.

Exclusion criteria

* patients who did not give consent, * patients with coagulopathy, * patients with signs of infection at the block application site, * patients using anticoagulants, * patients with known allergies to any of the study drugs, * patients with unstable hemodynamics, * patients who could not cooperate during postoperative pain assessment * patients who wanted to withdraw from the study, * patients with alcohol and drug addiction, * patients with musculoskeletal abnormalitie

Design outcomes

Primary

MeasureTime frameDescription
1. Numeric Rating Scale (NRS) ScoresPostoperative 24 hoursNumerical rating scale is used for pain assessment. The scores of the numerical rating scale changes between 0 to 10 points. 10 points mean the most severe pain that the patient ever had. 0 point means there is no pain. Higher scores mean worse outcome.

Secondary

MeasureTime frameDescription
Total tramadol consumptionPostoperative 24 hoursPostoperative total analgesic need was recorded as milligram in unit.

Countries

Turkey (Türkiye)

Contacts

Primary ContactOĞUZ GÜNDOĞDU
droguzgundogdu@gmail.com+905545945469
Backup ContactBUĞRA KARATAŞ
bugrabgr60@hotmail.com+905412453634

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026